Patents by Inventor Rahul R. JASUJA

Rahul R. JASUJA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TNFRSF25-MEDIATED TREATMENTS OF IMMUNE DISEASES AND DISORDERS
    Publication number: 20220340672
    Abstract: The present disclosure is directed to a method of treating or preventing diabetes, prediabetes, and/or glucose intolerance using TNF Receptor Superfamily Member 25 (TNFRSF25) agonistic antibody or antigen binding fragment thereof. The disclosure is also directed to methods for increasing graft survival and for treating or preventing graft-versus-host disease (GVHD) using TNFRSF25 agonistic antibody.
    Type: Application
    Filed: September 28, 2020
    Publication date: October 27, 2022
    Inventors: Matthew M. SEAVEY, Jeff T. HUTCHINS, Rahul R. JASUJA, A.M. James SHAPIRO, Braulio A. MARFIL-GARZA
  • METHODS OF TREATING CANCER USING TNFRSF25 ANTIBODIES
    Publication number: 20220298252
    Abstract: The present disclosure is directed to a method of treating cancer using a TNFRSF25 agonistic antibody or antigen binding fragment thereof and their combinations with additional therapies such as cancer vaccines and/or checkpoint inhibitors.
    Type: Application
    Filed: August 27, 2020
    Publication date: September 22, 2022
    Inventors: Matthew M. SEAVEY, Jeff T. HUTCHINS, Rahul R. JASUJA